A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NON RANDOMIZED · PARALLEL · PREVENTION · NONE
- Evidence population
- Human clinical study registration
- Participants
- 200
- Population
- ALL · 18 Years
- Duration
- 2018-08-15 to 2024-12-31
- Intervention
- Ambulation
- Comparator
- No Ambulator
- Outcomes measured
- Hospital Length of Stay — Through study completion, approximately 1 year post-transplant; Regular Nursing Floor Length of Stay — Through study completion, approximately 1 year post-transplant; 30-day readmission — Up to 30 days following discharge; Change in physical frailty phenotype — pre-transplant to 1 year following transplant; Change in short physical performance battery — pre-transplant to 1 year following transplant; Change in AMPAC/6-click score — pre-transplant to 1 year following transplant; Change in sarcopenia — pre-transplant to 1 year following transplant; Change in nutritional status; serum albumin — pre-transplant to 1 year following transplant; Change in nutritional status; serum protein — pre-transplant to 1 year following transplant; Change in nutritional status; BMI — pre-transplant to 1 year following transplant; Change in eyeball frailty assessment — pre-transplant to 1 year following transplant; Presence of aspiration — pre-transplant to 1 year following transplant; Readmission to ICU — Through study completion, approximately 1 year post-transplant; In-hospital falls — Through study completion, approximately 1 year post-transplant; Aspiration event — Through study completion, approximately 1 year post-transplant; Graft survival — Through study completion, approximately 1 year post-transplant; Accelerometer step change — pre-transplant (weeks to a year to more) and immediately after transplant, up to 1 year pos…; Accelerometer energy expenditure — pre-transplant (weeks to a year to more) and immediately after transplant, up to 1 y…; Accelerometer time ambulating — pre-transplant (weeks to a year to more) and immediately after transplant, up to 1 year…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.